Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM3B Inhibitors

FAM3B inhibitors belong to a specialized class of chemical compounds designed to modulate the activity of the FAM3B protein. FAM3B, also known as family with sequence similarity 3 member B, is a secreted protein that plays a crucial role in various physiological processes, including metabolism and inflammation. The inhibitors specifically target the catalytic or binding sites of FAM3B, aiming to disrupt its normal function or interaction with other biomolecules. The chemical structures of FAM3B inhibitors are carefully engineered to achieve high specificity and affinity for the target protein, thereby selectively inhibiting its activity without affecting other cellular processes. The design and development of FAM3B inhibitors involve a meticulous understanding of the protein's three-dimensional structure and the identification of key molecular interactions that can be exploited for inhibition. Researchers employ various computational and experimental techniques, such as structure-based drug design and high-throughput screening, to identify lead compounds with promising inhibitory properties. Subsequent optimization of these leads involves fine-tuning the chemical structure to enhance potency, selectivity, and pharmacokinetic properties. FAM3B inhibitors hold great promise as valuable tools in unraveling the intricacies of FAM3B-mediated pathways, contributing to a deeper understanding of the physiological and pathological roles of this protein. Their development represents a targeted approach to modulating FAM3B function, opening avenues for future research into novel interventions that leverage the intricate molecular mechanisms governed by FAM3B in various cellular processes.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

SIRT1 activator that modulates insulin signaling, possibly influencing FAM3B activity.

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$48.00
$122.00
$432.00
$812.00
4
(1)

GLUT1 inhibitor that may disrupt glucose uptake, indirectly affecting FAM3B's role in metabolic processes.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor that could alter FAM3B-related signaling by affecting the MAPK pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that may modify FAM3B's signaling through the PI3K/Akt pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor that can influence cellular growth and proliferation, processes in which FAM3B might be involved.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor potentially affecting inflammatory responses and insulin signaling linked to FAM3B.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

JNK inhibitor, could modulate stress response and insulin signaling pathways related to FAM3B activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor, which may impact cytoskeletal dynamics and related signaling influencing FAM3B function.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$94.00
$348.00
69
(1)

AMPK inhibitor also known as Compound C; could indirectly affect FAM3B-related metabolic processes.

GW 9662

22978-25-2sc-202641
5 mg
$68.00
30
(2)

PPARγ antagonist that may modulate lipid metabolism and glucose homeostasis involving FAM3B.